| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |